Eli Lilly & Co. (LLY) Announces Verzenio Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2
July 30, 2019 6:14 AM
Eli Lilly and Company (NYSE: LLY) today announced that Verzenio (abemaciclib) demonstrated a statistically significant improvement in overall survival in ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
